Pfizer to seek 3rd Covid-19 shot authorisation

WASHINGTON – Pfizer and BioNTech announced that they will seek regulatory authorisation for a third dose of their Covid-19 vaccine yesterday.

This comes after initial data from a trial showed a third shot pushed antibody levels five to 10 times higher against the original strain and the Beta variant compared with the first two doses alone, according to a statement.

To continue reading please click here

Leave a Reply

Back to top button